跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,085 条关于
“poly (L-lysine succinylated)”
全部
11,085
临床试验
7,611
药物
1,891
机构
107
资讯
1,476
去年
NIH Grants Exclusive License to Sangam Lifesciences for Novel Cancer Drug Delivery Platform
5年前
Comparative Analysis of PARP Inhibitors in BRCA-Mutated Ovarian Cancer Shows Similar Efficacy and Toxicity
6年前
PARP Inhibitors Show Similar Efficacy in BRCA-Mutated Ovarian Cancer, Cost-Effectiveness Varies
12年前
Niraparib Maintenance Therapy Demonstrates Sustained Benefit in Recurrent Ovarian Cancer
4年前
PARP Inhibitors Show Promise in Ovarian Cancer Maintenance Therapy
去年
Curapath and Cayman Chemical Partner to Expand Global Access to PEG-Free Lipids for Next-Generation LNP Therapies
11年前
PARP Inhibitors Show Promise in Epithelial Ovarian and Breast Cancers with BRCA1/2 Mutations
6年前
PARP Inhibitors in Frontline Ovarian Cancer Treatment: A Review of Clinical Trials
去年
DEP-SN38 Dendrimer Nanoparticle Shows Promise in Advanced Solid Tumors with Reduced Toxicity Profile
去年
PLL Therapeutics to Initiate Phase I/II Trial of PLL001 for Amyotrophic Lateral Sclerosis in Australia
第 1 页，共 148 页
上一页
下一页
